ResearcherAddenbrooke's HospitalNo recent work listed

Michail Galanopoulos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7544-2810; OpenAlex author ID A5042731625. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance. Last author DOI 10.1016/j.clinre.2022.101911 ↗
Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. Co-author DOI 10.3748/wjg.v27.i24.3568 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Apostolis Papaefthymiou · 1 shared paper, 2022 · strength 0.26
- Paper Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance. DOI 10.1016/j.clinre.2022.101911 ↗
Christos N. Liatsos · 1 shared paper, 2021 · strength 0.17
- Paper Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. DOI 10.3748/wjg.v27.i24.3568 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.